FPGEE Exam Flashcards

Q: What is the FPGEE pass rate?

The FPGEE pass rate was approximately 91% in 2024, according to NABP's 2024-2025 Annual Report. The exam uses scaled scoring from 0-100, and a score of 75 is required to pass.

Q: How many times can I retake the FPGEE if I fail?

Candidates may retake the FPGEE up to 5 times total within their 2-year FPGEC eligibility window. NABP administers the FPGEE only once per year at Pearson VUE sites in the continental US, so a failed attempt means waiting a full year for the next test date, not a short fixed waiting period like many other exams.

Q: What is on the FPGEE?

The FPGEE covers 4 blueprint domains: Basic Biomedical Sciences (12%), Pharmaceutical Sciences (31%), Social/Behavioral/Administrative Sciences (20%), and Pharmacy Practice & Clinical Sciences (37%, the largest domain). It has 200 computer-based, fixed-form questions over 4.5 hours (5.5-hour total seat time).

Q: Do I need a sponsor or job offer to take the FPGEE?

No employer sponsorship is required. Instead, candidates must first be accepted into NABP's FPGEC Certification process - which includes an education credential evaluation and a passing TOEFL iBT score - before they can register for the FPGEE.

Q: What comes after passing the FPGEE?

Passing the FPGEE, along with meeting TOEFL and credential requirements, leads to FPGEC certification. That certification makes a candidate eligible to sit for the NAPLEX and, ultimately, a state-specific pharmacy law exam (MPJE or equivalent) on the path to US pharmacist licensure.

Question 1

Where in the nephron are filtered glucose and amino acids reabsorbed, and which drug class targets this segment?

Accepted Answer

The proximal convoluted tubule (PCT) reabsorbs nearly all filtered glucose and amino acids along with most filtered sodium and water. SGLT2 inhibitors (the '-gliflozin' drugs) work by blocking glucose reabsorption at this exact segment.

Question 2

What does the Frank-Starling law describe, and why does it matter in fluid management?

Accepted Answer

Increased ventricular preload (venous return) stretches myocardial fibers and raises stroke volume, up to a physiologic limit. It explains why IV fluids raise cardiac output in hypovolemic shock but worsen congestion in decompensated heart failure.

Question 3

How does a competitive enzyme inhibitor change Km and Vmax compared to a noncompetitive inhibitor?

Accepted Answer

A competitive inhibitor raises the apparent Km (lower substrate affinity) while Vmax is unchanged, because excess substrate can outcompete it. A noncompetitive inhibitor instead lowers Vmax while Km stays the same, since it cannot be overcome by more substrate.

Question 4

What is the metabolic fate of pyruvate under aerobic versus anaerobic conditions?

Accepted Answer

Aerobically, pyruvate is converted to acetyl-CoA and enters the Krebs cycle for oxidative ATP production. Anaerobically (e.g., in maximally exercising muscle), pyruvate is instead reduced to lactate to regenerate NAD+ so glycolysis can continue.

Question 5

Which immunoglobulin crosses the placenta, and which one responds first in an acute infection?

Accepted Answer

IgG is the only immunoglobulin that crosses the placenta, giving passive immunity to a fetus/newborn. IgM is the first antibody produced during an acute immune response, appearing before IgG rises.

Question 6

How does Gram stain reflect a difference in bacterial cell wall structure, and why does it matter clinically?

Accepted Answer

Gram-positive organisms retain crystal violet due to a thick peptidoglycan wall; Gram-negative organisms have a thinner wall plus an outer membrane containing lipopolysaccharide (LPS/endotoxin), which drives their risk of endotoxin-mediated septic shock.

Question 7

How is apparent volume of distribution (Vd) calculated, and what does a very high Vd suggest about a drug?

Accepted Answer

Vd = Dose / C0 (initial plasma concentration). A high Vd (exceeding total body water) suggests extensive tissue binding or distribution outside plasma, as seen with digoxin; a low Vd suggests the drug stays mostly in plasma/extracellular fluid, as with warfarin.

Question 8

How many half-lives does it take to reach steady state, and does the dose or interval change that?

Accepted Answer

Steady state is reached in 4-5 half-lives (about 94% at 4, 97% at 5) regardless of the dose or dosing interval used. This is why maintenance dosing without a loading dose (e.g., amiodarone) can take days to weeks to reach a stable level.

Question 9

What equation estimates creatinine clearance for renal dose adjustments, and what variables feed into it?

Accepted Answer

The Cockcroft-Gault equation: CrCl = [(140 - age) x weight(kg)] / (72 x SCr), multiplied by 0.85 for females. It uses age, weight, serum creatinine, and sex, and is commonly used to dose renally-cleared drugs like vancomycin and DOACs.

Question 10

What distinguishes zero-order from first-order elimination kinetics?

Accepted Answer

Zero-order kinetics eliminate a constant AMOUNT of drug per unit time because the elimination pathway is saturated, as seen with phenytoin, ethanol, and high-dose aspirin. First-order kinetics (most drugs) eliminate a constant FRACTION per unit time, giving a constant half-life.

Question 11

Why does grapefruit juice raise blood levels of many statins and calcium channel blockers?

Accepted Answer

Grapefruit juice inhibits intestinal CYP3A4, the enzyme responsible for first-pass metabolism of most CYP3A4 substrates. Inhibiting it increases oral bioavailability and can push levels into a toxic range, such as simvastatin-induced myopathy.

Question 12

Why can codeine fail to relieve pain in a CYP2D6 poor metabolizer but cause toxicity in an ultra-rapid metabolizer?

Accepted Answer

Codeine is a prodrug that requires CYP2D6 to convert it into active morphine. Poor metabolizers get little to no analgesic effect, while ultra-rapid metabolizers can generate dangerously high morphine levels, a documented risk in breastfeeding mothers.

Question 13

What drug class does the stem '-sartan' identify, and how does its mechanism differ from an ACE inhibitor?

Accepted Answer

'-sartan' identifies angiotensin II receptor blockers (ARBs), such as losartan. Unlike ACE inhibitors, ARBs block the AT1 receptor directly rather than reducing ACE-mediated bradykinin breakdown, so they rarely cause the dry cough seen with ACE inhibitors.

Question 14

What does the drug stem '-gliflozin' indicate, and what benefit do these drugs share beyond glucose lowering?

Accepted Answer

'-gliflozin' identifies SGLT2 inhibitors (e.g., empagliflozin, dapagliflozin), which block proximal tubule glucose reabsorption. Beyond glycemic control, they have demonstrated cardiovascular and renal protective benefits in type 2 diabetes and heart failure.

Question 15

What drug class shares the stem '-floxacin,' and what safety warning applies to the whole class?

Accepted Answer

'-floxacin' identifies fluoroquinolone antibiotics (ciprofloxacin, levofloxacin). The class carries an FDA boxed warning for tendinitis/tendon rupture, peripheral neuropathy, and CNS effects, so it should be reserved when other options are inadequate.

Question 16

What calculation method combines two different-strength stock solutions into one target intermediate strength?

Accepted Answer

Alligation alternate: the difference between each stock strength and the desired strength sets the proportion (parts) of each solution needed, giving a quick mixing ratio without solving simultaneous equations.

Question 17

What reference point do pharmacists compare against when adjusting a parenteral or ophthalmic solution to be isotonic?

Accepted Answer

0.9% w/v sodium chloride (normal saline) is the standard isotonic reference. Calculated osmolarity (or a sodium chloride equivalent/freezing-point method) is compared to it, and a tonicity agent is added as needed to avoid tissue irritation or hemolysis.

Question 18

Why is the aliquot method used when a prescribed dose is too small to weigh accurately on a pharmacy balance?

Accepted Answer

A balance has a minimum accurately weighable quantity. The aliquot method dilutes the potent ingredient with an inert diluent to reach a larger, accurately weighable total, then measures a proportional aliquot that contains the correct original dose.

Question 19

What distinguishes USP <795> from USP <797> compounding standards?

Accepted Answer

USP <795> governs nonsterile compounding, such as oral suspensions and topical creams. USP <797> governs sterile compounding, such as IV admixtures and injections, with stricter environmental, garbing, and beyond-use-date requirements.

Question 20

Why does USP <800> exist as a separate standard alongside <795> and <797>?

Accepted Answer

USP <800> specifically addresses safe handling of hazardous drugs, such as antineoplastics, across the entire handling chain: receiving, storage, compounding, administration, and disposal, protecting personnel regardless of whether the preparation is sterile or nonsterile.

Question 21

What is the purpose of an enteric coating on an oral dosage form?

Accepted Answer

An enteric coating resists dissolution in the acidic stomach and dissolves in the higher pH of the small intestine, protecting acid-labile drugs (e.g., omeprazole) or protecting the stomach from irritating drugs (e.g., enteric-coated aspirin).

Question 22

Why can't a Schedule II prescription be refilled?

Accepted Answer

Federal law (Controlled Substances Act) prohibits refills on Schedule II drugs entirely. The patient needs an entirely new written or electronic prescription for each fill, reflecting the CSA's tightest control tier for high-abuse-potential drugs.

Question 23

How many refills are allowed on a Schedule III, IV, or V prescription, and within what time frame?

Accepted Answer

Schedule III-V prescriptions may be refilled up to 5 times within 6 months of the date issued. After that limit or time window, a new prescription is required.

Question 24

What lets a pharmacist dispense a Schedule II drug based on a verbal order, and what must happen afterward?

Accepted Answer

In a bona fide emergency, a prescriber may authorize a Schedule II drug orally. Under federal law (21 CFR 1306.11), the prescriber must then deliver a written or electronic prescription to the pharmacy within 7 days.

Question 25

What distinguishes a Schedule I from a Schedule II controlled substance?

Accepted Answer

Schedule I drugs have no accepted medical use and a high abuse potential, so they cannot be legally prescribed. Schedule II drugs (e.g., oxycodone, amphetamine salts) also have high abuse potential but DO have an accepted medical use and can be prescribed under strict controls.

Question 26

What does OBRA '90 require a pharmacist to do before dispensing a new prescription?

Accepted Answer

The Omnibus Budget Reconciliation Act of 1990 requires pharmacists to perform a prospective drug utilization review (screening for interactions, duplications, and contraindications) and to offer the patient counseling on new prescriptions.

Question 27

What is the main purpose of the Drug Supply Chain Security Act (DSCSA)?

Accepted Answer

DSCSA builds an electronic, interoperable system to trace prescription drugs as they move through the supply chain, helping identify and remove counterfeit, stolen, or otherwise unsafe products before they reach patients.

Question 28

What is a REMS program, and when does the FDA require one?

Accepted Answer

A Risk Evaluation and Mitigation Strategy (REMS) is a safety program the FDA can require for drugs with serious safety concerns, such as isotretinoin or clozapine, to ensure benefits outweigh risks through measures like prescriber certification or restricted distribution.

Question 29

What does a p-value of less than 0.05 mean in a clinical trial result?

Accepted Answer

It means the probability of observing that result (or a more extreme one) by chance alone, if the null hypothesis were true, is under 5%, the conventional threshold for statistical significance. It does not, by itself, indicate clinical importance.

Question 30

What does Number Needed to Treat (NNT) tell a clinician, and how should a lower NNT be interpreted?

Accepted Answer

NNT is the number of patients who must receive a treatment for one additional patient to benefit versus control. A lower NNT means a more effective or more potent treatment effect.

Question 31

How does a cost-utility analysis differ from a cost-effectiveness analysis in pharmacoeconomics?

Accepted Answer

Cost-effectiveness analysis compares cost per clinical outcome, such as cost per mmHg of blood pressure reduction. Cost-utility analysis standardizes outcomes using quality-adjusted life years (QALYs), allowing comparisons across different diseases and treatments.

Question 32

What A1C value confirms a diabetes diagnosis, and what range defines prediabetes?

Accepted Answer

An A1C of 6.5% or higher confirms diabetes per ADA criteria; 5.7% to 6.4% defines prediabetes. Diagnosis can also be confirmed with a fasting plasma glucose of 126 mg/dL or higher, or a 2-hour OGTT value of 200 mg/dL or higher.

Question 33

What is first-line pharmacotherapy for type 2 diabetes, and why?

Accepted Answer

Metformin remains first-line per ADA Standards of Care due to its efficacy, weight neutrality, low hypoglycemia risk, cardiovascular safety, and low cost, unless contraindicated (e.g., eGFR under 30 mL/min or conditions predisposing to lactic acidosis).

Question 34

Why do GLP-1 receptor agonists and SGLT2 inhibitors get preferential use in type 2 diabetics with cardiovascular or kidney disease?

Accepted Answer

Both classes showed cardiovascular and renal outcome benefits beyond glycemic control in outcome trials. GLP-1 agonists reduce major adverse cardiac events, and SGLT2 inhibitors reduce heart failure hospitalization and slow CKD progression, so they are recommended regardless of A1C control.

Question 35

How does diabetic ketoacidosis (DKA) differ from hyperosmolar hyperglycemic state (HHS)?

Accepted Answer

DKA presents with hyperglycemia, ketosis, and metabolic acidosis, typically in type 1 diabetics. HHS presents with much higher glucose, minimal ketosis/acidosis, and severe dehydration, typically in type 2 diabetics; both are treated with IV fluids, insulin, and electrolyte correction.

Question 36

How would a blood pressure reading of 135/85 mmHg be classified?

Accepted Answer

That falls into Stage 1 hypertension (systolic 130-139 or diastolic 80-89 mmHg). Below 120/80 is normal, 120-129/under 80 is elevated, and 140/90 or higher is Stage 2 hypertension.

Question 37

What INR range is targeted for most patients on warfarin for standard indications like AFib or DVT?

Accepted Answer

An INR of 2 to 3 is the target for most standard indications. Higher targets (2.5 to 3.5) apply to mechanical mitral valves and certain high-risk thrombotic conditions.

Question 38

Why don't DOACs such as apixaban or rivaroxaban require routine coagulation monitoring like warfarin?

Accepted Answer

DOACs have a predictable pharmacokinetic and pharmacodynamic profile with fixed dosing and fewer food/drug interactions, so routine INR-style monitoring isn't needed, though renal function should still be checked since most DOACs undergo some renal clearance.

Question 39

What drug classes make up the '4 pillars' of guideline-directed medical therapy for HFrEF?

Accepted Answer

An ACE inhibitor/ARB or ARNI (sacubitril-valsartan), a beta-blocker, a mineralocorticoid receptor antagonist, and an SGLT2 inhibitor together form the 4 pillars shown to reduce mortality and hospitalization in heart failure with reduced ejection fraction.

Question 40

What is the current target for vancomycin therapeutic drug monitoring, and why did it replace trough-only monitoring?

Accepted Answer

The 2020 ASHP/IDSA consensus guideline recommends an AUC/MIC ratio of 400-600 as the target, replacing the older trough-only approach (15-20 mcg/mL), because AUC-guided dosing better predicts efficacy while reducing nephrotoxicity risk.

Question 41

What does the CURB-65 score assess, and what does a score of 2 or higher generally indicate?

Accepted Answer

CURB-65 (Confusion, Urea, Respiratory rate, Blood pressure, age 65+) assesses community-acquired pneumonia severity. A score of 2 or higher generally indicates a need for hospital admission, while 3 or higher suggests considering ICU-level care.

Question 42

What are first-line treatment options for confirmed C. difficile infection?

Accepted Answer

Oral vancomycin or fidaxomicin are first-line per IDSA/SHEA guidance, with fidaxomicin preferred for its lower recurrence rate. Metronidazole is now reserved as an alternative only when the preferred agents are unavailable.

Question 43

Why should live attenuated vaccines generally be avoided in immunosuppressed patients?

Accepted Answer

Live vaccines, such as MMR and varicella, contain weakened but replicating pathogens that can cause actual disease in a patient whose immune system cannot control them. Inactivated or subunit vaccines are preferred in this population instead.

Question 44

How does GOLD staging classify COPD severity by FEV1?

Accepted Answer

GOLD 1 (mild): FEV1 80% or more of predicted; GOLD 2 (moderate): 50-79%; GOLD 3 (severe): 30-49%; GOLD 4 (very severe): under 30% predicted, used alongside symptoms and exacerbation history to guide treatment intensity.

Question 45

What is the first-line maintenance bronchodilator strategy for symptomatic COPD, and when are inhaled corticosteroids added?

Accepted Answer

A long-acting muscarinic antagonist (LAMA) or long-acting beta-agonist (LABA), often combined, forms first-line maintenance therapy. Inhaled corticosteroids are added mainly for patients with frequent exacerbations or elevated eosinophils, not used alone in COPD.

Question 46

How does asthma control assessment differ from COPD staging in guiding stepwise therapy?

Accepted Answer

Asthma (GINA guidelines) is managed by a stepwise approach based on symptom control and exacerbation risk, starting with as-needed ICS-formoterol. COPD (GOLD) is staged primarily by airflow limitation (FEV1) plus symptom/exacerbation grouping, since its obstruction is largely irreversible.

Question 47

What is first-line pharmacotherapy for major depressive disorder, and what is the classic triad of serotonin syndrome?

Accepted Answer

SSRIs are first-line for depression due to a favorable safety profile. Serotonin syndrome presents with altered mental status, autonomic instability (hyperthermia, tachycardia), and neuromuscular abnormalities (clonus, hyperreflexia), a risk when combining serotonergic agents.

Question 48

What is the therapeutic serum range for lithium, and what commonly precipitates toxicity?

Accepted Answer

Lithium's therapeutic range is 0.6-1.2 mEq/L. Because it is renally cleared with a narrow therapeutic index, dehydration, NSAIDs, and thiazide diuretics can precipitate toxicity, which starts with GI upset and tremor and can progress to confusion and seizures.

Question 49

What is the most common dose-limiting toxicity shared across many cytotoxic chemotherapy regimens?

Accepted Answer

Myelosuppression (neutropenia, thrombocytopenia, anemia) is the most common dose-limiting toxicity, since chemotherapy targets rapidly dividing cells, including bone marrow precursors. Nadir counts typically occur 7-14 days after administration.

Question 50

Why is febrile neutropenia in a chemotherapy patient treated as a medical emergency?

Accepted Answer

A neutropenic patient (ANC under 500-1000/mm3) with fever has a blunted immune response and can progress rapidly to sepsis, so empiric broad-spectrum antibiotics covering Pseudomonas should be started immediately, without waiting for culture results.

Free FPGEE Exam Flashcards

Filter by Topic

Jump to Card

About These FPGEE Flashcards

Topics Covered

Frequently Asked Questions

NABP FPGEE Foreign Pharmacy Graduate Examination

Explore More NABP Pharmacy Exams

NABP NAPLEX North American Pharmacist Licensure Examination

More From This Family